Embracing Diabetes Tech
Scott challenges the criticism surrounding the use of continuous glucose monitors and GLP-1 medications by individuals without diabetes, emphasizing that these tools can improve lives. He reassures listeners that pharmaceutical companies are equipped to handle demand, dispelling fears of shortages. Erika adds that criticism often stems from fear and uncertainty about how others' choices may impact them, questioning whether online platforms are the best place for such discussions.In this clip
From this podcast
Juicebox Podcast: Type 1 Diabetes
#884 Talking Online
Related Questions